Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Cancer Biology & Therapy|July 15, 2016
Anticancer potential of diarylidenyl piperidone derivatives, HO-4200 and H-4318, in cisplatin resistant primary ovarian cancerAdam C ElNaggar, Uksha Saini, Shan Naidu, et al.
Frontiers in Immunology|June 19, 2024
Enhanced IL-12 transgene expression improves oncolytic viroimmunotherapyYeaseul Kim, Uksha Saini, Doyeon Kim, et al.
Transgenic Research|August 29, 2013
Osmotin-expressing transgenic tea plants have improved stress tolerance and are of higher qualityAmita Bhattacharya, Uksha Saini, Robin Joshi, et al.
Acute Cardiac Care|December 11, 2012
Comparison of Impella and intra-aortic balloon pump in high-risk percutaneous coronary intervention: vascular complications and incidence of bleedingKonstantinos Dean Boudoulas, Andrew Pederzolli, Uksha Saini, et al.
Plos One|January 24, 2017
High Glucose-Mediated STAT3 Activation in Endometrial Cancer Is Inhibited by Metformin: Therapeutic Implications for Endometrial CancerJohn J Wallbillich, Srirama Josyula, Uksha Saini, et al.
Gynecologic Oncology|July 20, 2014
Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitorBrent J Tierney, Georgia A McCann, Shan Naidu, et al.
Journal of Ovarian Research|December 8, 2022
Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virusUksha Saini, Brentley Q Smith, Kalpana Deepa Priya Dorayappan, et al.
BMC Chemical Biology|June 1, 2011
Chemical modification of L-glutamine to alpha-amino glutarimide on autoclaving facilitates Agrobacterium infection of host and non-host plants: A new use of a known compoundIndra Sandal, Amita Bhattacharya, Uksha Saini, et al.
International Journal of Cancer|June 25, 2017
Targeting STAT3 by HO3867 induces apoptosis in ovarian clear cell carcinomaKristin Bixel, Uksha Saini, Hemant Kumar Bid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2020
Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor ImmunityBangxing Hong, Valerie Chapa, Uksha Saini, et al.
Pageof 3